Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 9.30
0.00 (0.00%)
At close: May 29, 2026
BUL:THQM Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 34.69 | 32.73 | 27.24 | 24.8 | 22.06 | 21.7 |
| 34.69 | 32.73 | 27.24 | 24.8 | 22.06 | 21.7 | |
Revenue Growth (YoY) | 21.39% | 20.17% | 9.83% | 12.46% | 1.65% | 5.84% |
Cost of Revenue | 7.18 | 9.79 | 10.42 | 17.15 | 6.55 | 15.73 |
Gross Profit | 27.52 | 22.94 | 16.82 | 7.66 | 15.51 | 5.97 |
Selling, General & Admin | 21.22 | 17.55 | 12.68 | 3.75 | 12.26 | 2.9 |
Other Operating Expenses | 0.41 | 0.34 | 0.15 | 0.42 | -0.14 | 0.33 |
Operating Expenses | 23.15 | 19.37 | 14.12 | 5.61 | 13.95 | 5.22 |
Operating Income | 4.37 | 3.58 | 2.7 | 2.05 | 1.56 | 0.75 |
Interest Expense | -0.22 | -0.23 | -0.3 | -0.28 | -0.14 | -0.14 |
Interest & Investment Income | 0.3 | 0.3 | 0.24 | 0.24 | 0.24 | 0.23 |
Currency Exchange Gain (Loss) | -0.01 | - | -0.04 | -0 | -0.03 | -0.03 |
Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
EBT Excluding Unusual Items | 4.42 | 3.63 | 2.58 | 1.98 | 1.6 | 0.8 |
Pretax Income | 4.42 | 3.63 | 2.58 | 1.98 | 1.6 | 0.8 |
Income Tax Expense | 0.35 | 0.34 | 0.28 | 0.24 | 0.17 | 0.09 |
Net Income | 4.07 | 3.29 | 2.3 | 1.74 | 1.43 | 0.71 |
Net Income to Common | 4.07 | 3.29 | 2.3 | 1.74 | 1.43 | 0.71 |
Net Income Growth | 53.39% | 42.87% | 32.46% | 21.89% | 99.78% | 226.30% |
Shares Outstanding (Basic) | 96 | 96 | 96 | 93 | 93 | 93 |
Shares Outstanding (Diluted) | 96 | 96 | 96 | 93 | 93 | 93 |
Shares Change (YoY) | -0.81% | - | 3.38% | - | - | 38.72% |
EPS (Basic) | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS (Diluted) | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS Growth | 54.65% | 42.87% | 28.13% | 21.90% | 99.78% | 135.25% |
Free Cash Flow | 1.63 | 1.27 | 0.61 | 0.49 | 0.45 | 0.23 |
Free Cash Flow Per Share | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
Gross Margin | 79.31% | 70.08% | 61.76% | 30.87% | 70.31% | 27.49% |
Operating Margin | 12.58% | 10.92% | 9.92% | 8.26% | 7.06% | 3.43% |
Profit Margin | 11.73% | 10.05% | 8.45% | 7.01% | 6.47% | 3.29% |
Free Cash Flow Margin | 4.69% | 3.87% | 2.25% | 1.97% | 2.04% | 1.06% |
EBITDA | 5.64 | 4.81 | 3.98 | 3.48 | 3.26 | 2.71 |
EBITDA Margin | 16.26% | 14.68% | 14.62% | 14.04% | 14.78% | 12.50% |
D&A For EBITDA | 1.27 | 1.23 | 1.28 | 1.43 | 1.7 | 1.97 |
EBIT | 4.37 | 3.58 | 2.7 | 2.05 | 1.56 | 0.75 |
EBIT Margin | 12.58% | 10.92% | 9.92% | 8.26% | 7.06% | 3.43% |
Effective Tax Rate | 7.95% | 9.31% | 10.73% | 12.14% | 10.92% | 10.74% |
Revenue as Reported | 34.68 | 32.76 | - | - | - | 21.76 |